United Therapeutics Stock Price (NASDAQ:UTHR)

Add to My Stocks
$126.2 $0.26 (0.21%) UTHR stock closing price Sep 18, 2018 (Closing)
Prev Close* : $125.94
Market Cap:
$5.49B
Day Low: $124.42
52 Week Low: $100.57
Open: $126
Volume: -
Day High: $127.74
52 Week High: $152.55
Dividend:
0.00

Latest Stock Market News

Latest Articles

United Therapeutics News - From Partners

UTHR Stockcharts

View UTHR PE ratio, PS ratio stocks charts and compare with peers.
UTHR Chart
Note: Compare United Therapeutics stock price history with the index and industry peers.

United Therapeutics Valuation

PE ratio
(price earnings ratio)
7.77
PS ratio (
price to sales ratio
)
3.12
PB ratio (
price to book ratio
)
2.5

United Therapeutics Returns

ROE
(return on equity)
33%

United Therapeutics Financial Ratios

Asset Turnover
0.57
Receivables Turnover
6.79
Debt to Equity
0.1
Dividend Yield
0%

UTHR Industry Peers

Company Price Change (%)
Stada Arzneimi (STDAF)96.10 (0%)
Questcor Pharma (QCOR)93.61.52 (1.65%)
Pfizer (PFE)43.510.5 (1.16%)
Baxter International (BAX)77.240.2 (0.26%)
Correvio Pharma (CORV)4.440.14 (3.26%)
Eiger Biopharma (EIGR)11.70 (0%)
Arna Pharma (ARNA)42.040.46 (1.11%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ChemoCentryx (CCXI)11.521.03 (9.82%)
AcelRx Pharma (ACRX)3.750.3 (8.7%)
MELINTA THERAPT (MLNT)4.450.35 (8.54%)
Galectin Therapeutics (GALT)6.020.28 (4.88%)
GlycoMimetics (GLYC)14.580.67 (4.82%)
Achaogen (AKAO)4.280.17 (4.14%)
Concert Pharma (CNCE)13.420.51 (3.95%)
Top gainers from Medical-Drugs industry
* As of Sep 19, 2018
CompanyPriceChange (%)
MADRIGAL PHARMA (MDGL)207.321.13 (9.25%)
Tetraphase Pharmaceuticals (TTPH)2.90.16 (5.23%)
Recro Pharma (REPH)7.410.29 (3.77%)
Corcept Therapeutics (CORT)14.260.48 (3.26%)
Lannett Co (LCI)4.750.15 (3.06%)
Catalyst Pharma (CPRX)3.10.09 (2.82%)
Galmed Pharma (GLMD)12.610.24 (1.87%)
Top losers from Medical-Drugs industry
* As of Sep 19, 2018

United Therapeutics Corporation Stock News - Partner Headlines

United Therapeutics Financial Statements

income statement20172016201520142013
Net Sales or Revenues1.73B1.6B1.47B1.29B1.12B
Net Income417.9M713.7M651.63M340.07M174.56M
Total Operating Expense804.7M464.4M697.7M623.82M693.35M
View United Therapeutics income statement
balance sheet20172016201520142013
Total Assets2.88B2.33B2.18B1.88B2.09B
Total Liabilities777.6M474.3M595.89M642.05M828.29M
Shareholders Equity2.1B1.85B1.59B1.24B1.26B
View United Therapeutics balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-78.4M-117.4M-202.18M-385.55M-216.66M
Net Cash from (used by) Operating Activities474.2M643.6M382.76M355.25M425.26M
Increase (Decrease) in Prop Plant And Equipment-78M-38M-49.79M-47.43M-31.91M
View United Therapeutics cash flow statement

United Therapeutics Stock Message Board

An investor needs to spend $126.2 to buy UTHR stock, as the closing United Therapeutics stock price is $126.2. United Therapeutics market capitalization is $5.49B and it represents the total market value of UTHR stock. A value investor must look at the fundamentals of a stock, and perform United Therapeutics valuation, even though in the short-term, sentiment and current breaking news might affect United Therapeutics stock price.

The terms stocks and shares mean the same thing. For Ex: United Therapeutics stock price and United Therapeutics share price mean the same thing. 288,769 UTHR shares were traded yesterday, and United Therapeutics stock chart shows that the UTHR stock quote hit a day high of $127.74 and day low of $124.42. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. United Therapeutics does not pay dividends. United Therapeutics stock price history, gives the entire historical data for UTHR stock.